Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response?
Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Journal Article: Investigative radiology (impact factor: 4.85). 09/2011; 47(1):65-70. DOI: 10.1097/RLI.0b013e31823003d2
Abstract
Twenty-four consecutive patients (5 women aged 61 ± 10 years) with metastatic GIST underwent DECT of the abdomen (80 kV, 140 kV) using first-generation dual-source computed tomography (CT). All patients had at least one or more liver lesions (median, 4; maximum, 9). Image data were processed with a dedicated DECT software algorithm designed for evaluation of iodine distribution in soft tissue lesions, and VNE CT images were generated. The tumor density (according to Choi criteria) and the maximum transverse diameter of the lesions (according to Response Evaluation Criteria in Solid Tumors [RECIST]) were determined. TNE and VNE lesion attenuation and Choi criteria and IRA were correlated with each other.
A total of 291 liver lesions were evaluated, of which 220 were cystic and 71 were solid. The mean lesion size was 4.5 ± 3.2 cm (1.1-18.7 cm). The mean attenuation of all lesions was significantly higher in the TNE images than in the VNE images (P=0.0001). Pearson statistics revealed an excellent correlation of r=0.843 (P=0.0001) between IRA and Choi criteria for all lesions. DECT showed significantly higher IRA in progressive (23.3 ± 9.5 HU) lesions compared with stable or regressive (17.8 ± 9.1 HU) lesions (P=0.0185). Similarly, the Choi criteria differed significantly between progressive (39.9 ± 12.8 HU) and stable/regressive (31.1 ± 10.3 HU) lesions (P=0.0003).
DECT is a promising imaging method for the assessment of treatment response in GIST, as IRA might be a more robust response parameter than the Choi criteria. VNE CT data calculated from DECT may eliminate the need for acquisition of a separate unenhanced data set.
Source: PubMed
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate.
World journal of gastroenterology : WJG. 14(6):892-8.
We should desist using RECIST, at least in GIST.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(13):1760-4.
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(13):1753-9.
Targeted therapies in renal cell cancer: recent developments in imaging.
Targeted oncology. 5(2):95-112.
Response evaluation of gastrointestinal stromal tumors.
The oncologist. 13 Suppl 2:4-7.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
Science & Research Jobs
W3-Professorship in "Energy Economics and Energy Systems"
Position: Professor (Full)
Employer: University of Stuttgart
Scientist for Medical Signal Processing-ECG interpretation algorithm in Philips Research Asia – Shanghai
Position: Researcher
Employer: Philips (China) Investment Co.,Ltd

